D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Donegal Group Class A
DGICA
$711M
| $868K | ﹤0.01% |
44,194
-1,284
| -3% | -$20.9K |
|
3052
HighPeak Energy
HPK
$811M
| $867K | ﹤0.01% |
68,494
+17,052
| +33% | +$229K |
|
3053
Entravision Communication
EVC
$1.01B
| $864K | ﹤0.01% |
411,327
-42,254
| -9% | -$92.4K |
|
3054
Immunovant
IMVT
$7.99B
| $864K | ﹤0.01% |
50,534
-17,135
| -25% | -$358K |
|
3055
Wave Life Sciences
WVE
$1.13B
| $861K | ﹤0.01% |
106,554
-609,699
| -85% | -$6.67M |
|
3056
PUT
StoneCo
STNE
$2.71B
| $860K | ﹤0.01% |
82,100
-382,700
| -82% | -$3.61M |
|
3057
Hanover Insurance
THG
$7.84B
| $860K | ﹤0.01% |
+4,946
| New | +$801K |
|
3058
CALL
DuPont de Nemours
DD
$19B
| $859K | ﹤0.01% |
9,162
+6,772
| +283% | +$661K |
|
|
RDFN
3059
CALL
DELISTED
Redfin
RDFN
| $858K | ﹤0.01% |
93,200
+22,500
| +32% | +$192K |
|
3060
iShares MSCI Japan Small-Cap ETF
SCJ
$250M
| $857K | ﹤0.01% |
11,169
| – | – |
|
3061
Adeia
ADEA
$2.77B
| $855K | ﹤0.01% |
+64,704
| New | +$901K |
|
|
UCB
3062
United Community Banks
UCB
$4.27B
| $855K | ﹤0.01% |
+30,391
| New | +$951K |
|
3063
Orthofix Medical
OFIX
$496M
| $854K | ﹤0.01% |
52,380
+6,221
| +13% | +$109K |
|
3064
Nicolet Bankshares
NIC
$3.65B
| $851K | ﹤0.01% |
7,810
+4,149
| +113% | +$466K |
|
3065
Rivian
RIVN
$24.2B
| $850K | ﹤0.01% |
+68,246
| New | +$859K |
|
|
AVDX
3066
DELISTED
AvidXchange
AVDX
| $848K | ﹤0.01% |
+100,037
| New | +$925K |
|
3067
Invesco S&P 500 Revenue ETF
RWL
$9.67B
| $848K | ﹤0.01% |
8,535
| – | – |
|
3068
Artisan Partners
APAM
$2.9B
| $847K | ﹤0.01% |
+21,675
| New | +$918K |
|
3069
Gladstone Investment Corp
GAIN
$655M
| $847K | ﹤0.01% |
63,412
+45,778
| +260% | +$614K |
|
3070
Amphastar Pharmaceuticals
AMPH
$888M
| $846K | ﹤0.01% |
29,188
-89,663
| -75% | -$2.86M |
|
3071
Southwest Airlines
LUV
$22.7B
| $845K | ﹤0.01% |
25,163
+16,090
| +177% | +$510K |
|
3072
DT Midstream
DTM
$14.1B
| $842K | ﹤0.01% |
+8,731
| New | +$874K |
|
3073
Ingevity
NGVT
$2.59B
| $838K | ﹤0.01% |
21,167
-7,983
| -27% | -$353K |
|
3074
CALL
Vital Farms
VITL
$592M
| $838K | ﹤0.01% |
27,500
+13,700
| +99% | +$493K |
|
3075
Takeda Pharmaceutical
TAK
$56B
| $833K | ﹤0.01% |
+56,036
| New | +$785K |
|
Similar funds
D.E. Shaw & Co's Q1 2025 Portfolio in Review
As of Q1 2025, D.E. Shaw & Co held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- D.E. Shaw & Co's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- D.E. Shaw & Co added most to GE Vernova in Q1 2025, an estimated $686M increase.
- D.E. Shaw & Co's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- D.E. Shaw & Co opened 569 new positions and closed 704 in Q1 2025.
- D.E. Shaw & Co's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.